A Phase 3 interventional study of Buprenorphine and Fentanyl in Pain, sponsored by University of Aarhus. Completed at 1 site in Denmark. Open to male participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2012-09-14.
Sponsored by University of Aarhus · Phase 3 and Interventional
To compare the analgesic and anti-hyperalgesic effect of Buprenorphine and Fentanyl against experimental pain in skin, muscle and bone. The study will be performed with healthy volunteers.
University of Aarhus is the lead sponsor of 1,274 studies on the registry; 183 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: Buprenorphine
Drug: Fentanyl
Drug: Placebo
Buprenorphine: 20microg/h
Also known as: Norspan
Fentanyl: 25microg/h
Also known as: Durogesic
Placebo: '5microg/h' (not active drug, it is just called '5microg/h')
Also known as: Norspan
Data will be electronically recorded or written directly in case report form. Outcome measure will be a subjective rating of the pain with a visual analogue scale.
Time frame: Continuously
This study is completed, as verified in Sep 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Aarhus